Mohamed Khairie Issa - Jan 6, 2025 Form 4 Insider Report for INCYTE CORP (INCY)

Role
EVP, Head of US Oncology
Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
Stock symbol
INCY
Transactions as of
Jan 6, 2025
Transactions value $
$0
Form type
4
Date filed
1/8/2025, 04:11 PM
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INCY Common Stock Award $0 +48.7K $0.00 48.7K Jan 6, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.
F2 Includes the January 6, 2025 aggregate grant of 48,671 shares of common stock.